New studies designed to understand the specific processes resulting in these phenomena (i.e., the release of amyloid beta peptides and dysregulation of hemin pathways resulting in hemin-amyloid beta species) may uncover key processes related to the origins of Alzheimer’s and related neurodegenerative diseases. The gene discussed is APP; the disease is neurodegenerative disease.